News / Taiwan / cnyes
Analysts Lower 2026 EPS Forecast for Bora Pharmaceuticals to NT$17.43
Health Technology · Pharmaceuticals: Major · cnyes · 2026-09-08
6472
Following a recent FactSet survey, analysts have adjusted their 2026 EPS forecast for Bora Pharmaceuticals downward to NT$17.43, with a target price of NT$505.
What Happened
Earnings Forecast Revision: A recent FactSet survey of 8 analysts indicates a downward revision for Bora Pharmaceuticals (6472-TW), with the median 2026 EPS estimate lowered from NT$19.16 to NT$17.43.
Target Price: Despite the adjustment in earnings expectations, the consensus target price for the company remains set at NT$505.
Market Sentiment: Analysts hold varying views on the company's future performance, with estimates ranging from a high of NT$24.97 to a low of NT$14.86, highlighting uncertainty regarding future profitability.
Disclaimer: This information is based on FactSet data and is intended for reference only; it should not be construed as investment advice.